Light Therapy in Modulating the Clinical Phenotype of Patients With Primary and Comorbid Chronic Insomnia. (Luminoterapia)
Insomnia Chronic
About this trial
This is an interventional treatment trial for Insomnia Chronic focused on measuring Light therapy
Eligibility Criteria
Inclusion Criteria: Primary chronic insomnia Comorbid chronic insomnia Absence of pharmacological therapy of insomnia Absence of behavioural and cognitive treatment of insomnia Capacity to understand the study and adhere to the procedures Written informed consent Exclusion Criteria: Secondary insomnia due to medical conditions or drug treatment Cerebral diseases Invalidating diseases Eye diseases that contraindicate the use of light therapy Psychiatric disorders Cognitive decline Working in night shifts during the last month before enrolment Impossibility to provide informed consent
Sites / Locations
- Istituto Auxologico ItalianoRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Luminette
Sham
Patients without ocular contraindications undergo a Luminotherapy protocol (intermittent blue-enriched light therapy with Luminette 10000 lux equivalent) with morning or evening timing, depending on the circadian phase.
Control group (white light <100 lux equivalent).